$299.00 Million in Sales Expected for Navient Corp (NASDAQ:NAVI) This Quarter

Share on StockTwits

Equities analysts predict that Navient Corp (NASDAQ:NAVI) will post sales of $299.00 million for the current quarter, according to Zacks. Three analysts have made estimates for Navient’s earnings, with the highest sales estimate coming in at $312.00 million and the lowest estimate coming in at $279.00 million. Navient posted sales of $298.00 million in the same quarter last year, which suggests a positive year over year growth rate of 0.3%. The firm is expected to issue its next earnings report after the market closes on Tuesday, July 23rd.

On average, analysts expect that Navient will report full year sales of $1.15 billion for the current financial year, with estimates ranging from $1.11 billion to $1.19 billion. For the next year, analysts anticipate that the firm will post sales of $1.11 billion, with estimates ranging from $1.02 billion to $1.16 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Navient.

Navient (NASDAQ:NAVI) last released its quarterly earnings data on Tuesday, April 23rd. The credit services provider reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.12. Navient had a net margin of 6.99% and a return on equity of 15.10%. The firm had revenue of $285.00 million for the quarter, compared to analysts’ expectations of $304.67 million. During the same quarter in the previous year, the company earned $0.43 earnings per share.

NAVI has been the subject of a number of recent analyst reports. BMO Capital Markets raised Gold Fields from a “market perform” rating to an “outperform” rating in a report on Thursday, April 25th. Oppenheimer cut Gulfport Energy from an “outperform” rating to a “market perform” rating in a report on Friday, April 5th. JPMorgan Chase & Co. reiterated a “hold” rating and issued a $7.00 price objective on shares of Deutsche Bank in a research report on Thursday, April 25th. BidaskClub lowered Zynerba Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Thursday, July 11th. Finally, ValuEngine lowered Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st. Five equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $15.10.

Shares of NAVI traded down $0.02 during mid-day trading on Friday, reaching $13.53. The company had a trading volume of 1,499,271 shares, compared to its average volume of 1,767,434. Navient has a twelve month low of $8.23 and a twelve month high of $14.48. The company has a quick ratio of 12.43, a current ratio of 12.43 and a debt-to-equity ratio of 25.60. The stock’s 50-day moving average price is $13.38. The stock has a market cap of $3.24 billion, a P/E ratio of 6.47, a P/E/G ratio of 2.09 and a beta of 2.11.

The business also recently announced a quarterly dividend, which was paid on Friday, June 21st. Investors of record on Friday, June 7th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.73%. The ex-dividend date of this dividend was Thursday, June 6th. Navient’s dividend payout ratio (DPR) is presently 30.62%.

In other Navient news, EVP Stephen M. Hauber sold 9,000 shares of Navient stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $13.63, for a total transaction of $122,670.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.85% of the stock is owned by company insiders.

A number of institutional investors have recently added to or reduced their stakes in NAVI. BlackRock Inc. increased its position in shares of Navient by 3.3% in the fourth quarter. BlackRock Inc. now owns 23,806,736 shares of the credit services provider’s stock valued at $209,740,000 after buying an additional 763,973 shares in the last quarter. MFN Partners Management LP purchased a new stake in Navient during the 1st quarter worth about $7,521,000. JPMorgan Chase & Co. increased its position in Navient by 293.8% during the 1st quarter. JPMorgan Chase & Co. now owns 863,940 shares of the credit services provider’s stock worth $9,996,000 after purchasing an additional 644,550 shares in the last quarter. Sapience Investments LLC purchased a new stake in Navient during the 1st quarter worth about $6,384,000. Finally, Fir Tree Capital Management LP purchased a new stake in Navient during the 4th quarter worth about $3,550,000. 94.09% of the stock is owned by institutional investors.

About Navient

Navient Corporation provides education loan management and business processing solutions for education, healthcare, and government clients at the federal, state, and local levels in the United States. It operates in three segments: Federal Education Loans, Consumer Lending, and Business Processing. The company holds and acquires Federal Family Education Loan Program loans that are insured or guaranteed by state or not-for-profit agencies; and performs servicing and asset recovery services on its own loan portfolio, and federal education loans owned by the United States Department of Education and other institutions.

See Also: Ex-Dividend

Get a free copy of the Zacks research report on Navient (NAVI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Navient (NASDAQ:NAVI)

Receive News & Ratings for Navient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navient and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

BABB  Price Reaches $0.0001 on Exchanges
BABB Price Reaches $0.0001 on Exchanges
Eterbase Tops 1-Day Volume of $392,818.00
Eterbase Tops 1-Day Volume of $392,818.00
Analyzing Dime Community Bancshares  and First Guaranty Bancshares
Analyzing Dime Community Bancshares and First Guaranty Bancshares
Brokerages Expect Flexion Therapeutics Inc  to Post -$0.98 EPS
Brokerages Expect Flexion Therapeutics Inc to Post -$0.98 EPS
Jesus Coin Price Tops $0.0000 on Major Exchanges
Jesus Coin Price Tops $0.0000 on Major Exchanges
ShowHand  Trading Down 54.4% This Week
ShowHand Trading Down 54.4% This Week


 
© 2006-2019 Zolmax.